Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| HEALTHEQUITY, INC.HQY · Entity 3639 | Director · FOUNDER AND VICE CHAIRMAN | October 06, 2026 | October 08, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
HEALTHEQUITY, INC.
Report date October 06, 2026 · Filed October 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 136,470 |
Reported balance
After 2026-10-06 transaction · row 1
1 source rowRow 1 · 2026-10-06 · Tax withholding · Disposed 1,095 · Balance 136,470 |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 408,235 |
Reported balance
Holding disclosure · report date 2026-10-06 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 408,235 F1: Shares held of record by the Stephen and Christine Neeleman Trust. |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 140,000 |
Reported balance
Holding disclosure · report date 2026-10-06 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 140,000 F2: The securities are beneficially owned by the Reporting Person's spouse. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose. |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 203,000 |
Reported balance
Holding disclosure · report date 2026-10-06 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 203,000 F3: Shares held of record by Neeleman Family Holdings, LLC ("Family Holdings"), a Utah limited liability company. The reporting person is the manager of Family Holdings. The reporting person disclaims beneficial ownership of the shares held by Family Holdings except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of the shares held by Family Holdings for any other purposes. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $41.28 · Expires 2027-03-27 | Direct | 19,897 |
Reported balance
Holding disclosure · report date 2026-10-06 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 19,897 F4: The option is immediately exercisable. |
| Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $61.72 · Expires 2028-03-27 | Direct | 14,228 |
Reported balance
Holding disclosure · report date 2026-10-06 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 14,228 F4: The option is immediately exercisable. |
| Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $73.61 · Expires 2029-03-26 | Direct | 15,337 |
Reported balance
Holding disclosure · report date 2026-10-06 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 15,337 F4: The option is immediately exercisable. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares held of record by the Stephen and Christine Neeleman Trust.
F2: The securities are beneficially owned by the Reporting Person's spouse. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.
F3: Shares held of record by Neeleman Family Holdings, LLC ("Family Holdings"), a Utah limited liability company. The reporting person is the manager of Family Holdings. The reporting person disclaims beneficial ownership of the shares held by Family Holdings except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of the shares held by Family Holdings for any other purposes.
F4: The option is immediately exercisable.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 08, 2023 Filed Dec 12, 2023 20:56 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | SaleCommon Stock | 300 | $70.01 | $21,003.99 |
DisclosureSEC source: 0001415889-23-016295 · form4-12122023_081248.xml · nonDerivative · entry 4 Neeleman Stephen · CIK 0001614838 · Director · FOUNDER AND VICE CHAIRMAN 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,887 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.0100 to $70.0200, inclusive. Read SEC document |
| December 08, 2023 Filed Dec 12, 2023 20:56 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | SaleCommon Stock | 7,122 | $69.09 | $492,079.63 |
DisclosureSEC source: 0001415889-23-016295 · form4-12122023_081248.xml · nonDerivative · entry 3 Neeleman Stephen · CIK 0001614838 · Director · FOUNDER AND VICE CHAIRMAN 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,187 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.8700 to $69.6500, inclusive. Read SEC document |
| December 08, 2023 Filed Dec 12, 2023 20:56 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | SaleCommon Stock | 62,578 | $68.51 | $4,286,962.21 |
DisclosureSEC source: 0001415889-23-016295 · form4-12122023_081248.xml · nonDerivative · entry 2 Neeleman Stephen · CIK 0001614838 · Director · FOUNDER AND VICE CHAIRMAN 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,309 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.8700 to $68.8600, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), and (3) of this Form 4 Read SEC document |
| December 08, 2023 Filed Dec 12, 2023 20:56 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Exercise / conversionCommon Stock | 70,000 | $14.00 | $980,000.00 |
DisclosureSEC source: 0001415889-23-016295 · form4-12122023_081248.xml · nonDerivative · entry 1 Neeleman Stephen · CIK 0001614838 · Director · FOUNDER AND VICE CHAIRMAN 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 142,887 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 04, 2023 Filed Oct 6, 2023 21:54 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Tax withholdingCommon Stock | 312 | $72.06 | $22,483.59 |
DisclosureSEC source: 0001415889-23-014048 · form4-10062023_091035.xml · nonDerivative · entry 3 Neeleman Stephen · CIK 0001614838 · Director · FOUNDER AND VICE CHAIRMAN 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,887 Read SEC document |
| October 02, 2023 Filed Oct 6, 2023 21:54 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | GiftCommon Stock | 4,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-014048 · form4-10062023_091035.xml · nonDerivative · entry 1 Neeleman Stephen · CIK 0001614838 · Director · FOUNDER AND VICE CHAIRMAN 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 564,235 F1 · ownership.nature: Shares held of record by the Stephen and Christine Neeleman Trust. Read SEC document |
| July 05, 2023 Filed Jul 7, 2023 21:45 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Tax withholdingCommon Stock | 317 | $62.18 | $19,710.49 |
DisclosureSEC source: 0001415889-23-010962 · form4-07072023_090743.xml · nonDerivative · entry 1 Neeleman Stephen · CIK 0001614838 · Director · FOUNDER AND VICE CHAIRMAN 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,199 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.1781 to $62.1782, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) of this Form 4. Read SEC document |
| April 04, 2023 Filed Apr 5, 2023 20:39 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Tax withholdingCommon Stock | 1,886 | $55.99 | $105,588.46 |
DisclosureSEC source: 0001415889-23-006290 · form4-04052023_080449.xml · nonDerivative · entry 2 Neeleman Stephen · CIK 0001614838 · Director · FOUNDER AND VICE CHAIRMAN 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,516 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.9854 to $55.9855, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) of this Form 4. Read SEC document |
| April 03, 2023 Filed Apr 5, 2023 20:39 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Tax withholdingCommon Stock | 4,429 | $57.70 | $255,549.31 |
DisclosureSEC source: 0001415889-23-006290 · form4-04052023_080449.xml · nonDerivative · entry 1 Neeleman Stephen · CIK 0001614838 · Director · FOUNDER AND VICE CHAIRMAN 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,402 Read SEC document |
| March 29, 2023 Filed Mar 31, 2023 20:17 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | GrantCommon Stock | 13,057 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-005663 · form4-03312023_080305.xml · nonDerivative · entry 2 Neeleman Stephen · CIK 0001614838 · Director · FOUNDER AND VICE CHAIRMAN 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,831 F2 · shares: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vested as to 13,057 shares on March 29, 2023. Read SEC document |
| March 29, 2023 Filed Mar 31, 2023 20:17 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | GrantCommon Stock | 15,006 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-005663 · form4-03312023_080305.xml · nonDerivative · entry 1 Neeleman Stephen · CIK 0001614838 · Director · FOUNDER AND VICE CHAIRMAN 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,774 F1 · shares: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Shares vest as to 25% of the initial award on April 1, 2024. Shares shall vest as to 6.25% thereafter on the first day of each calendar quarter for the twelve calendar quarters following April 1, 2024. Read SEC document |
| December 27, 2022 Filed Dec 29, 2022 16:02 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | GiftCommon Stock | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-013056 · form4-12292022_041253.xml · nonDerivative · entry 2 Neeleman Stephen · CIK 0001614838 · Director · FOUNDER AND VICE CHAIRMAN 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 568,735 F1 · ownership.nature: Shares held of record by the Stephen and Christine Neeleman Trust. Read SEC document |
| June 30, 2022 Filed Dec 29, 2022 16:02 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | GiftCommon Stock | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-013056 · form4-12292022_041253.xml · nonDerivative · entry 1 Neeleman Stephen · CIK 0001614838 · Director · FOUNDER AND VICE CHAIRMAN 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 570,735 F1 · ownership.nature: Shares held of record by the Stephen and Christine Neeleman Trust. Read SEC document |
| April 19, 2022 Filed May 9, 2022 21:26 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | GiftCommon Stock | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-004773 · form4-05092022_020553.xml · nonDerivative · entry 1 Neeleman Stephen · CIK 0001614838 · Director · FOUNDER AND VICE CHAIRMAN 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 573,735 F1 · ownership.nature: Shares held of record by the Stephen and Christine Neeleman Trust. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 21:28 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Tax withholdingCommon Stock | 3,434 | $67.63 | $232,242.79 |
DisclosureSEC source: 0001179110-22-002616 · edgar.xml · nonDerivative · entry 1 Neeleman Stephen · CIK 0001614838 · Director · Founder and Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,768 F1 · balance_after: Corrects an overstatement of shares held by the reporting person in the reporting person's most recent Form 4. Read SEC document |
| March 31, 2022 Filed Apr 1, 2022 18:42 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Tax withholdingCommon Stock | 584 | $67.48 | $39,409.60 |
DisclosureSEC source: 0001179110-22-002498 · edgar.xml · nonDerivative · entry 3 Neeleman Stephen · CIK 0001614838 · Director · Founder and Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,825 Read SEC document |
| March 30, 2022 Filed Apr 1, 2022 18:42 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | GrantCommon Stock | 11,152 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-002498 · edgar.xml · nonDerivative · entry 2 Neeleman Stephen · CIK 0001614838 · Director · Founder and Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,409 F2 · shares: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Shares vest as to 25% of the initial award on April 1, 2023. Shares shall vest as to 6.25% thereafter on the first day of each calendar quarter for the twelve calendar quarters following April 1, 2023. Read SEC document |
| March 30, 2022 Filed Apr 1, 2022 18:42 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | GrantCommon Stock | 9,535 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-002498 · edgar.xml · nonDerivative · entry 1 Neeleman Stephen · CIK 0001614838 · Director · Founder and Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,257 F1 · shares: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vested as to 9,535 shares on March 30, 2022. Read SEC document |
| April 05, 2021 Filed Apr 7, 2021 15:10 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Tax withholdingCommon Stock | 2,321 | $67.29 | $156,185.89 |
DisclosureSEC source: 0001179110-21-004280 · edgar.xml · nonDerivative · entry 2 Neeleman Stephen · CIK 0001614838 · Director · Founder and Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,722 F1 · balance_after: The shares reported on this Form 4 are subject to a lock-up agreement between the reporting person and BofA Securities, Inc. dated February 16, 2021 (the "Lock-up Date") pursuant to which the remaining shares reported in Table I of this Form 4 cannot be sold for 45 days following the Lock-up Date. Read SEC document |
| April 05, 2021 Filed Apr 7, 2021 15:10 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Tax withholdingCommon Stock | 2,128 | $67.29 | $143,198.44 |
DisclosureSEC source: 0001179110-21-004280 · edgar.xml · nonDerivative · entry 1 Neeleman Stephen · CIK 0001614838 · Director · Founder and Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,043 Read SEC document |
| March 31, 2021 Filed Apr 1, 2021 20:36 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Tax withholdingCommon Stock | 641 | $67.50 | $43,268.91 |
DisclosureSEC source: 0001179110-21-003941 · edgar.xml · nonDerivative · entry 3 Neeleman Stephen · CIK 0001614838 · Director · Founder and Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,171 F3 · balance_after: The shares reported on this Form 4 are subject to a lock-up agreement between the reporting person and BofA Securities, Inc. dated February 16, 2021 (the "Lock-up Date") pursuant to which the remaining shares reported in Table I of this Form 4 cannot be sold for 45 days following the Lock-up Date. Read SEC document |
| March 30, 2021 Filed Apr 1, 2021 20:36 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | GrantCommon Stock | 6,465 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-003941 · edgar.xml · nonDerivative · entry 2 Neeleman Stephen · CIK 0001614838 · Director · Founder and Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,812 F2 · shares: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vested as to 6,465 shares on March 30, 2021. Read SEC document |
| March 30, 2021 Filed Apr 1, 2021 20:36 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | GrantCommon Stock | 7,463 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-003941 · edgar.xml · nonDerivative · entry 1 Neeleman Stephen · CIK 0001614838 · Director · Founder and Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,347 F1 · shares: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units will vest as to 1,866 shares annually on March 30, 2022, 2023 and 2024. The remaining 1,865 restricted stock units vest on March 30, 2025. Read SEC document |
| October 01, 2020 Filed Jan 25, 2021 17:23 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | GiftCommon Stock | 550 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-000808 · edgar.xml · nonDerivative · entry 2 Neeleman Stephen · CIK 0001614838 · Director · Founder and Vice Chairman 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 575,735 F1 · ownership.nature: Shares held of record by the Stephen and Christine Neeleman Trust. Read SEC document |
| April 06, 2020 Filed Apr 7, 2020 20:22 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Tax withholdingCommon Stock | 8,969 | $43.97 | $394,323.88 |
DisclosureSEC source: 0001179110-20-004740 · edgar.xml · nonDerivative · entry 1 Neeleman Stephen · CIK 0001614838 · Director · Founder and Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,884 Read SEC document |
| March 31, 2020 Filed Apr 2, 2020 18:41 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | GrantCommon Stock | 8,236 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-004484 · edgar.xml · nonDerivative · entry 4 Neeleman Stephen · CIK 0001614838 · Director · Founder and Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,853 F4 · shares: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest in four equal installments of 2,059 shares on each of March 31, 2021, 2022, 2023, and 2024. Read SEC document |
| March 31, 2020 Filed Apr 2, 2020 18:41 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | GrantCommon Stock | 19,073 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-004484 · edgar.xml · nonDerivative · entry 3 Neeleman Stephen · CIK 0001614838 · Director · Founder and Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,617 F3 · shares: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vested as to 19,073 shares on March 31, 2020. Read SEC document |
| March 31, 2020 Filed Apr 2, 2020 18:41 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | GrantCommon Stock | 3,623 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-004484 · edgar.xml · nonDerivative · entry 2 Neeleman Stephen · CIK 0001614838 · Director · Founder and Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,544 F2 · shares: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest as to 3,623 shares on the date of the meeting of the Company's compensation committee to be held in the first quarter of the fiscal year ended January 31, 2023. Read SEC document |
| March 31, 2020 Filed Apr 2, 2020 18:41 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | GrantCommon Stock | 7,921 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-004484 · edgar.xml · nonDerivative · entry 1 Neeleman Stephen · CIK 0001614838 · Director · Founder and Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,921 F1 · shares: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest as to 7,921 shares on the date of the meeting of the Company's compensation committee to be held in the first quarter of the fiscal year ended January 31, 2022. Read SEC document |
| July 12, 2019 Filed Jul 15, 2019 20:43 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | PurchaseCommon Stock | 10,000 | $61.00 | $610,000.00 |
DisclosureSEC source: 0001179110-19-008643 · edgar.xml · nonDerivative · entry 2 Neeleman Stephen · CIK 0001614838 · Director · Founder and Vice Chairman 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 576,285 F1 · ownership.nature: Shares held of record by the Stephen and Christine Neeleman Trust. Read SEC document |
| March 26, 2019 Filed Mar 28, 2019 21:13 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | GrantStock Option (right to buy) · Derivative | 15,337 | $0.00 Strike: $73.61 | $0.00 |
DisclosureSEC source: 0001179110-19-004365 · edgar.xml · derivative · entry 7 Neeleman Stephen · CIK 0001614838 · Director · Founder and Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,337 Underlying: Common Stock · 15,337 shares Expires 2029-03-26 F7 · derivative.exercise_date: The option becomes exercisable as to 3,835 shares on March 27, 2020. The remaining option vests as to 3,384 shares on each of March 27, 2021, 2022 and 2023. Read SEC document |
| March 26, 2019 Filed Mar 28, 2019 21:13 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | GrantStock Option (right to buy) · Derivative | 80,000 | $0.00 Strike: $14.00 | $0.00 |
DisclosureSEC source: 0001179110-19-004365 · edgar.xml · derivative · entry 6 Neeleman Stephen · CIK 0001614838 · Director · Founder and Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,000 Underlying: Common Stock · 80,000 shares Expires 2024-07-30 F5 · shares: On July 30, 2014, the reporting person was granted an option to purchase 200,000 shares of common stock. The option vests in annual installments based on the issuer's satisfaction of certain performance criteria for each of the fiscal years ending January 31, 2016 (10%), 2017 (20%), 2018 (30%) and 2019 (40%). The performance criteria for 2019 were met, resulting in the vesting of the option as to 80,000 shares. F6 · derivative.exercise_date: The option is immediately exercisable. Read SEC document |
| June 12, 2018 Filed Jun 18, 2018 22:35 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | GiftCommon Stock | 17,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-008724 · edgar.xml · nonDerivative · entry 2 Neeleman Stephen · CIK 0001614838 · Director · Founder and Vice Chairman 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 566,285 F1 · ownership.nature: Shares held of record by the Stephen and Christine Neeleman Trust. Read SEC document |
| May 10, 2018 Filed May 11, 2018 00:38 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Exercise / conversionStock Option (right to buy) · Derivative | 8,889 | $0.00 Strike: $14.00 | $0.00 |
DisclosureSEC source: 0001179110-18-006594 · edgar.xml · derivative · entry 23 Neeleman Stephen · CIK 0001614838 · Director · Founder and Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 8,889 shares Expires 2024-07-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 23, 2018. F18 · derivative.exercise_date: The option is immediately exercisable. Read SEC document |
| May 10, 2018 Filed May 11, 2018 00:38 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | SaleCommon Stock | 10,934 | $70.21 | $767,634.59 |
DisclosureSEC source: 0001179110-18-006594 · edgar.xml · nonDerivative · entry 19 Neeleman Stephen · CIK 0001614838 · Director · Founder and Vice Chairman 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 203,000 F6 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by Neeleman Family Holdings, LLC, a Utah limited liability company, on March 23, 2018. F17 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.64 to $70.58, inclusive. F8 · ownership.nature: Shares held of record by Neeleman Family Holdings, LLC ("Family Holdings"), a Utah limited liability company. The reporting person is the manager of Family Holdings. The reporting person disclaims beneficial ownership of the shares held by Family Holdings except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of the shares held by Family Holdings for any other purposes. Read SEC document |
| May 10, 2018 Filed May 11, 2018 00:38 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | SaleCommon Stock | 32,802 | $70.21 | $2,302,903.77 |
DisclosureSEC source: 0001179110-18-006594 · edgar.xml · nonDerivative · entry 18 Neeleman Stephen · CIK 0001614838 · Director · Founder and Vice Chairman 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 583,285 F3 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Stephen and Christine Neeleman Trust on March 23, 2018. F16 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.64 to $70.58, inclusive. F5 · ownership.nature: Shares held of record by the Stephen and Christine Neeleman Trust. Read SEC document |
| May 10, 2018 Filed May 11, 2018 00:38 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | SaleCommon Stock | 8,889 | $70.21 | $624,062.91 |
DisclosureSEC source: 0001179110-18-006594 · edgar.xml · nonDerivative · entry 17 Neeleman Stephen · CIK 0001614838 · Director · Founder and Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The option exercises and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 23, 2018. F15 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.64 to $70.58, inclusive. Read SEC document |
| May 10, 2018 Filed May 11, 2018 00:38 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Exercise / conversionCommon Stock | 8,889 | $14.00 | $124,446.00 |
DisclosureSEC source: 0001179110-18-006594 · edgar.xml · nonDerivative · entry 16 Neeleman Stephen · CIK 0001614838 · Director · Founder and Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,889 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 23, 2018. Read SEC document |
| May 09, 2018 Filed May 11, 2018 00:38 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Exercise / conversionStock Option (Right to Buy) · Derivative | 13,926 | $0.00 Strike: $14.00 | $0.00 |
DisclosureSEC source: 0001179110-18-006594 · edgar.xml · derivative · entry 22 Neeleman Stephen · CIK 0001614838 · Director · Founder and Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,889 Underlying: Common Stock · 13,926 shares Expires 2024-07-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 23, 2018. F18 · derivative.exercise_date: The option is immediately exercisable. Read SEC document |
| May 09, 2018 Filed May 11, 2018 00:38 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | SaleCommon Stock | 3,809 | $70.66 | $269,128.32 |
DisclosureSEC source: 0001179110-18-006594 · edgar.xml · nonDerivative · entry 15 Neeleman Stephen · CIK 0001614838 · Director · Founder and Vice Chairman 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 213,934 F6 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by Neeleman Family Holdings, LLC, a Utah limited liability company, on March 23, 2018. F14 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.54 to $70.89, inclusive. F8 · ownership.nature: Shares held of record by Neeleman Family Holdings, LLC ("Family Holdings"), a Utah limited liability company. The reporting person is the manager of Family Holdings. The reporting person disclaims beneficial ownership of the shares held by Family Holdings except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of the shares held by Family Holdings for any other purposes. Read SEC document |
| May 09, 2018 Filed May 11, 2018 00:38 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | SaleCommon Stock | 13,318 | $70.15 | $934,277.68 |
DisclosureSEC source: 0001179110-18-006594 · edgar.xml · nonDerivative · entry 14 Neeleman Stephen · CIK 0001614838 · Director · Founder and Vice Chairman 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 217,743 F6 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by Neeleman Family Holdings, LLC, a Utah limited liability company, on March 23, 2018. F13 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.54 to $70.53, inclusive. F8 · ownership.nature: Shares held of record by Neeleman Family Holdings, LLC ("Family Holdings"), a Utah limited liability company. The reporting person is the manager of Family Holdings. The reporting person disclaims beneficial ownership of the shares held by Family Holdings except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of the shares held by Family Holdings for any other purposes. Read SEC document |
| May 09, 2018 Filed May 11, 2018 00:38 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | SaleCommon Stock | 11,426 | $70.66 | $807,314.31 |
DisclosureSEC source: 0001179110-18-006594 · edgar.xml · nonDerivative · entry 13 Neeleman Stephen · CIK 0001614838 · Director · Founder and Vice Chairman 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 616,087 F3 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Stephen and Christine Neeleman Trust on March 23, 2018. F12 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.54 to $70.89, inclusive. F5 · ownership.nature: Shares held of record by the Stephen and Christine Neeleman Trust. Read SEC document |
| May 09, 2018 Filed May 11, 2018 00:38 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | SaleCommon Stock | 39,954 | $70.15 | $2,802,837.03 |
DisclosureSEC source: 0001179110-18-006594 · edgar.xml · nonDerivative · entry 12 Neeleman Stephen · CIK 0001614838 · Director · Founder and Vice Chairman 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 627,513 F3 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Stephen and Christine Neeleman Trust on March 23, 2018. F11 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.54 to $70.53, inclusive. F5 · ownership.nature: Shares held of record by the Stephen and Christine Neeleman Trust. Read SEC document |
| May 09, 2018 Filed May 11, 2018 00:38 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | SaleCommon Stock | 3,097 | $70.66 | $218,821.63 |
DisclosureSEC source: 0001179110-18-006594 · edgar.xml · nonDerivative · entry 11 Neeleman Stephen · CIK 0001614838 · Director · Founder and Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The option exercises and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 23, 2018. F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.54 to $70.89, inclusive. Read SEC document |
| May 09, 2018 Filed May 11, 2018 00:38 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | SaleCommon Stock | 10,829 | $70.15 | $759,670.59 |
DisclosureSEC source: 0001179110-18-006594 · edgar.xml · nonDerivative · entry 10 Neeleman Stephen · CIK 0001614838 · Director · Founder and Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,097 F1 · kind: The option exercises and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 23, 2018. F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.54 to $70.53, inclusive. Read SEC document |
| May 09, 2018 Filed May 11, 2018 00:38 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Exercise / conversionCommon Stock | 13,926 | $14.00 | $194,964.00 |
DisclosureSEC source: 0001179110-18-006594 · edgar.xml · nonDerivative · entry 9 Neeleman Stephen · CIK 0001614838 · Director · Founder and Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,926 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 23, 2018. Read SEC document |
| May 08, 2018 Filed May 11, 2018 00:38 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Exercise / conversionStock Option (right to buy) · Derivative | 17,185 | $0.00 Strike: $14.00 | $0.00 |
DisclosureSEC source: 0001179110-18-006594 · edgar.xml · derivative · entry 21 Neeleman Stephen · CIK 0001614838 · Director · Founder and Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,815 Underlying: Common Stock · 17,185 shares Expires 2024-07-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 23, 2018. F18 · derivative.exercise_date: The option is immediately exercisable. Read SEC document |
| May 08, 2018 Filed May 11, 2018 00:38 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Exercise / conversionStock Option (right to buy) · Derivative | 654 | $0.00 Strike: $1.25 | $0.00 |
DisclosureSEC source: 0001179110-18-006594 · edgar.xml · derivative · entry 20 Neeleman Stephen · CIK 0001614838 · Director · Founder and Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 654 shares Expires 2021-08-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 23, 2018. F18 · derivative.exercise_date: The option is immediately exercisable. Read SEC document |
| May 08, 2018 Filed May 11, 2018 00:38 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | SaleCommon Stock | 24 | $70.25 | $1,686.00 |
DisclosureSEC source: 0001179110-18-006594 · edgar.xml · nonDerivative · entry 8 Neeleman Stephen · CIK 0001614838 · Director · Founder and Vice Chairman 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 231,061 F6 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by Neeleman Family Holdings, LLC, a Utah limited liability company, on March 23, 2018. F8 · ownership.nature: Shares held of record by Neeleman Family Holdings, LLC ("Family Holdings"), a Utah limited liability company. The reporting person is the manager of Family Holdings. The reporting person disclaims beneficial ownership of the shares held by Family Holdings except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of the shares held by Family Holdings for any other purposes. Read SEC document |
| May 08, 2018 Filed May 11, 2018 00:38 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | SaleCommon Stock | 21,915 | $69.59 | $1,525,005.68 |
DisclosureSEC source: 0001179110-18-006594 · edgar.xml · nonDerivative · entry 7 Neeleman Stephen · CIK 0001614838 · Director · Founder and Vice Chairman 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 231,085 F6 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by Neeleman Family Holdings, LLC, a Utah limited liability company, on March 23, 2018. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.21 to $70.14, inclusive. F8 · ownership.nature: Shares held of record by Neeleman Family Holdings, LLC ("Family Holdings"), a Utah limited liability company. The reporting person is the manager of Family Holdings. The reporting person disclaims beneficial ownership of the shares held by Family Holdings except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of the shares held by Family Holdings for any other purposes. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.